0 followers
Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evaluate investment and collaborative opportunities in benign hematology, infectious diseases, transfusion medicin... Read more
This company has no teams yet